Background Image
Table of Contents Table of Contents
Previous Page  25 / 658 Next Page
Information
Show Menu
Previous Page 25 / 658 Next Page
Page Background

3

Analyte

Start

Time

(min)

Stop

Time

(min)

Ionization

Mode

Precursor

Ion Mass

(

m/z

)

Product

Ion Mass

(

m/z

)

Collision

Energy

(V)

Tube

Lens

(V)

Levetiracetam

0.9

1.8

+

171.1

69.3

28

70

171.1

126.2

13

171.1

154.1

5

IS7

0.9

1.8

+

174.1

69.3

29

70

Theophylline

0.9

1.9

+

181.0

69.3

26

110

181.0

96.2

24

181.0

124.1

17

IS8

0.9

1.9

+

187.0

127.1

19

110

Felbamate

1.3

2.3

+

239.0

91.2

34

100

239.0

117.1

16

239.0

178.0

5

Rufinamide

1.3

2.3

+

239.0

127.1

23

100

239.0

211.0

5

239.0

222.0

11

IS5

1.3

2.3

+

243.0

182.1

5

100

Lacosamide

1.3

2.3

+

251.1

91.2

27

100

251.1

108.2

7

251.1

116.1

13

IS6

1.3

2.3

+

254.1

108.2

6

100

Carbamazepine diol

1.7

2.7

+

271.0

180.0

27

100

271.0

236.0

11

271.0

253.1

5

Carbamazepine-10,11-epoxide

1.9

2.8

+

253.0

180.1

29

100

253.0

210.0

13

253.0

236.0

12

10-hydroxycarbamazepine

1.9

2.9

+

255.0

179.0

36

100

255.0

194.0

19

255.0

237.0

5

IS3

1.9

2.9

+

259.0

198.0

19

100

IS2

1.9

2.9

+

263.1

190.1

25

100

IS4

2.4

3.4

+

257.0

184.0

25

100

257.0

212.0

19

257.0

240.0

13

Oxcarbazepine

2.5

3.5

+

253.0

180.0

25

100

253.0

208.0

19

253.0

236.0

11

Carbamazepine

2.9

3.9

+

237.0

165.0

42

100

237.0

179.1

32

237.0

194.0

19

IS1

2.9

3.9

+

247.1

204.1

20

100

Table 3. SRM settings – Group 1